24 April, 2014 02:13 IST
News
Dr Reddys gets USFDA nod for Sildenafil tablets
Source: IRIS (19-NOV-12)
Comments  |  Post Comment

Dr Reddys Laboratories, an integrated global pharmaceutical company,  announced that it has launched Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

It has received approval by the United States Food & Drugs Administration (USFDA) for ANDA Sildenafil tablets.

The Revatio brand had US sales of approximately USD 338.67 million for the most recent 12 months ending September 2012 according to IMS health.

Shares of the company gained Rs 16, or 0.91%, to trade at Rs 1,773.35. The total volume of shares traded was 755 at the BSE (9.32 a.m., Monday).



Dr Reddy`S Laboratories Limited   (Q,N,C,F)*


Live News
FMC Technologies Q1 profit jumps - 23-Apr-2014 19:38
Wonderla Holidays IPO subscribed nearly 38 times on closing day - 23-Apr-2014 19:27
Sanmina Corp Q2 earnings decline - 22-Apr-2014 00:00
Lennox International Q1 earnings surge - 22-Apr-2014 00:00
Pentair Q1 profit more than doubles as margins expand - 23-Apr-2014 17:55
Gulfmark Offshore Q1 profit jumps on healthy sales, margin - 22-Apr-2014 00:00
INR weakens against USD, down marginally to settle at 61.09 - 23-Apr-2014 17:36
Irobot Corp Q1 profit plunges - 23-Apr-2014 17:28
Amsurg Corp Q1 profit drops - 23-Apr-2014 17:25
Omnicom Group Q1 flat at $205.50 million - 23-Apr-2014 17:19
Cairn India consolidated Q4 profit climbs 18.4% - 23-Apr-2014 17:13
more...
* Q - Quote , N - News , C - Chart , F - Financials
Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type   kxfp8j into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Forums  |   E-mail  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer